Hôpital Armand Trousseau
Paris, 75012, France
NCT Number: NCT02267161
The purpose of this study is to assess the neurological development at three years of age of children born after prenatal diagnosis of "isolated" agenesis of the corpus callosum.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75012, France
Agenesis of the corpus callosum is the most frequent brain malformation. This anomaly may be diagnosed by ultrasound screening. In half of these prenatal cases, the anomaly seems to be isolated. In this setting, there are no prospective data concerning the development of these children, preventing any clear information to be delivered to parents. Prenatal diagnostic centers therefore face extremely variable rates of termination of pregnancies (TOP), which can reach up to 80%.
This is a multicentric prospective interventional study whose primary objective is to assess the neurological development at three years of age of children born after prenatal diagnosis of "isolated" agenesis of the corpus callosum.
Evaluation at three years will include Intellectual Quotient (IQ) quantification using the WPPSI-III, 3rd edition of Wechsler Preschool and Primary Scale of Intelligence and evaluation of intra-hemispheric coordination using the Vineland adaptative behaviour scale.
Secondary objectives will include:
These results could allow to determine the optimal prenatal management of such cases.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
WPPSI-III, VINELAND, CBCL, NEPSY
Time frame: 3 years
Neurodevelopment outcome
Time frame: 3 years
Neurodevelopment outcome
Time frame: 3 years
Neurodevelopment outcome
Time frame: 3 years
Neurodevelopment outcome
Time frame: up to 3 years
Assistance Publique - Hôpitaux de Paris
Other
Outcome of Infants With Prenatal Corpus Callosum Agenesis
Acronym: DACCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03600792
Agenesis of Corpus Callosum, Congenital Abnormalities
Paris, France
View Trial DetailsNCT02167568
Agenesis of Corpus Callosum, Cerebral Abnormality
Paris, France
View Trial DetailsNCT03463239
Accidental Injuries, Agenesis of Corpus Callosum
Winston-Salem, North Carolina, United States
View Trial DetailsNCT07611058
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Lille, France
View Trial Details